Our sister publication Keystone Edge writes about Malvern biopharmacetucial startup Recro Pharma, among the new breed of companies presenting at the annual Biotech 2010 conference in Philadelphia.
There's no denying that the down economy has been rough for the life sciences sector. When industry news website FiercePharma listed the 10 companies that laid off the most workers in 2009, seven firms on the list had a presence in the Keystone State. But Chris Molineaux, president of the statewide advocacy group Pennsylvania Bio that is hosting its annual Biotech 2010 event next week, says the upheaval of Big Pharma represents a new model for the industry.No longer will huge companies try to do every task under one corporate banner, Molineaux says. Already, it's increasingly common to outsource tasks like information technology, financing and the administrative aspects of clinical drug trials. Researchers remain in-house or come to a company through an acquisition."It's going to be more of a patchwork. We're not going to have 15 large pharmaceutical companies," Molineaux says. "We'll probably have 50 medium-sized pharmaceutical companies and dozens of these smaller contractors."Original source: Keystone Edge
Read the full story here.